Background: The Omicron variant of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is the most mutated variant identified and contributed to the third wave of the coronavirus disease-19 (COVID-19) pandemic. Due to its high transmissibility, it has replaced the Delta variant, which was the dominant variant during the second wave of the pandemic. Aims and Objectives: This study aims to evaluate whether the highly transmissible, rapidly multiplying, and frequently transforming Omicron variant of SARS-CoV-2 affects the performance of rapid antigen tests (RAT) in the third wave of the COVID-19 pandemic. Materials and Methods: This retrospective study was conducted in a tertiary care hospital in the initial period of the third wave of the COVID-19 pandemic. Socio-demographic information was collectedfrom 480 patients whose nasopharyngeal swabs were received for both RAT and reverse transcription-polymerase chain reaction (RT-PCR) testing. Results: Male preponderance was seen in all patients’ age groups. Substantial agreement between RAT and gold standard RT-PCR was observed. When samples that tested positive by RAT were further analyzed with RT-PCR, most of them showed a cycle threshold value below 25, indicating a higher viral load. Sensitivity, specificity, positive predictive value, negative predictive value, positive likelihood ratio, and negative likelihood ratio of the COVID-19 RAT were 46.03%, 99.52%, 93.54%, 92.42%, 95.87%, and 0.54%, respectively. Conclusion: The RAT shows high specificity and good agreement with RT-PCR results, making it suitable as a quick point-of-care screening tool, especially in hospitals and areas with high infection rates. TheOmicron variant did not significantly affect the performance of RAT.
No takes yet. Share an insight, caveat, or question.
Joshi et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: